Unlike normal cells, stem cells are pluripotent — they can become any cell type, which makes them powerful potential treatments for diseases such as diabetes, leukemia and age-related blindness.
Stem cells that have been specifically developed for use as clinical therapies are fit for use in patients, an independent study of their genetic make-up suggests.
New research reveals how an injectable hydrogel boosted stem cell transplantation, partially restoring vision in blind mice and repairing brain injury after stroke.
Although the potential therapeutic uses of human embryonic stem cells have been known since 1981, until now, the long-term safety of these transplantations had not been assessed.
The curative and therapeutic potential of mesenchymal stem cells (MSCs) offers much promise, as these multipotent cells are currently being tested in more than 300 clinical trials in a range of diseases.
Previously, stem cells have been cultivated using animal proteins or by growing them from other human cells. Both methods come with associated problems. But, according to a study published in the journal Applied Materials & Interfaces, researchers have now identified a new method for cultivating stem cells.
Research led by a biology professor in the School of Science at IUPUI has uncovered a method to produce retinal cells from regenerative human stem cells without the use of animal products, proteins or other foreign substances, which historically have l…